Back
PTC Therapeutics Stock Price Chart

Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
PTCT
PTC Therapeutics
Last Price:
$57.10
Seasonality Move:
12.15%
7 Day Trial
ALL ACCESS PASS
$
7

Apple just traded your privacy for $20 Billion
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTC Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.53 | Buy |
20-day SMA: | 53.35 | Buy |
50-day SMA: | 49.41 | Buy |
200-day SMA: | 40.82 | Buy |
8-day EMA: | 55.69 | Buy |
20-day EMA: | 53.68 | Buy |
50-day EMA: | 50.57 | Buy |
200-day EMA: | 42.66 | Buy |
PTC Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.02 | Buy |
Relative Strength Index (14 RSI): | 65.59 | Buy |
Chaikin Money Flow: | 780140 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.19 - 55.19) | Buy |
Bollinger Bands (100): | (42.59 - 51.39) | Buy |
PTC Therapeutics Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for PTC Therapeutics Stock
Is PTC Therapeutics Stock a Buy?
-
PTC Therapeutics share price is 57.14 while PTCT 8-day simple moving average is 55.53, which is a Buy signal.
-
The stock price of PTCT is 57.14 while PTC Therapeutics 20-day SMA is 53.35, which makes it a Buy.
-
PTC Therapeutics 50-day simple moving average is 49.41 while PTCT share price is 57.14, making it a Buy technically.
-
PTCT stock price is 57.14 and PTC Therapeutics 200-day simple moving average is 40.82, creating a Buy signal.
PTCT Technical Analysis vs Fundamental Analysis
Sell
43
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy or a Sell?
-
PTC Therapeutics stock is rated a SellThe current PTC Therapeutics [PTCT] share price is $57.14. The Score for PTCT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
PTC Therapeutics Stock Info
Market Cap:
4.5B
Price in USD:
57.14
Share Volume:
1M
PTC Therapeutics 52-Week Range
52-Week High:
58.38
52-Week Low:
24.00
Sell
43
PTC Therapeutics (PTCT)
is a Sell
PTC Therapeutics Share Price Forecast
-
What is the PTC Therapeutics stock price today?The PTC Therapeutics stock price is 57.14 USD today.
-
Will PTCT stock go up or go down?PTC Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is PTC Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, PTC Therapeutics is overvalued.
Is PTC Therapeutics Stock a Buy?
-
PTC Therapeutics share price is 57.14 while PTCT 8-day exponential moving average is 55.69, which is a Buy signal.
-
The stock price of PTCT is 57.14 while PTC Therapeutics 20-day EMA is 53.68, which makes it a Buy.
-
PTC Therapeutics 50-day exponential moving average is 50.57 while PTCT share price is 57.14, making it a Buy technically.
-
PTCT stock price is 57.14 and PTC Therapeutics 200-day simple moving average is 42.66, creating a Buy signal.
Fundamental Analysis of PTC Therapeutics
Is PTC Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $1.60 per share.
Technical Analysis of PTC Therapeutics
Should I short PTC Therapeutics stock?
-
PTCT Moving Average Covergence Divergence (MACD) indicator is 2.02, suggesting PTC Therapeutics is a Buy
-
PTC Therapeutics Relative Strength Index (RSI) is 65.59, which suggest PTC Therapeutics is overbought
-
The Bollinger Bands (25) for PTC Therapeutics is (50.19 - 55.19), which suggest PTC Therapeutics is a Buy
-
The Bollinger Bands (100) for PTC Therapeutics is (42.59 - 51.39), which suggest PTC Therapeutics is a Buy
* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.